We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Philip Morris
PM
$298B
| $183M | 0.67% |
1,877,523
+17,343
| +0.9% | +$1.66M |
|
27
Entegris
ENTG
$20.6B
| $181M | 0.66% |
1,666,999
-108,316
| -6% | -$9.88M |
|
|
ATVI
28
DELISTED
Activision Blizzard
ATVI
| $178M | 0.65% |
2,153,581
+833,189
| +63% | +$67.4M |
|
29
McDonald's
MCD
$187B
| $176M | 0.65% |
595,287
-27,375
| -4% | -$7.95M |
|
30
Nike
NKE
$60.8B
| $169M | 0.62% |
1,538,547
-2,577
| -0.2% | -$301K |
|
31
Keysight
KEYS
$55.6B
| $169M | 0.62% |
1,025,869
+6,926
| +0.7% | +$1.07M |
|
32
Mondelez International
MDLZ
$77.1B
| $160M | 0.58% |
2,189,244
-14,856
| -0.7% | -$1.1M |
|
33
NextEra Energy
NEE
$187B
| $157M | 0.57% |
2,113,331
-118,803
| -5% | -$8.99M |
|
34
Copart
CPRT
$25.2B
| $156M | 0.57% |
3,418,256
-35,030
| -1% | -$1.45M |
|
35
ASML
ASML
$693B
| $155M | 0.57% |
213,744
-1,910
| -0.9% | -$1.3M |
|
36
American Tower
AMT
$76.7B
| $137M | 0.5% |
708,575
-103,416
| -13% | -$20.2M |
|
37
Marriott International
MAR
$96.1B
| $127M | 0.46% |
690,565
-11,783
| -2% | -$2.04M |
|
|
38
AbbVie
ABBV
$454B
| $119M | 0.44% |
885,465
-369,484
| -29% | -$54.2M |
|
39
American Express
AXP
$233B
| $98.9M | 0.36% |
567,667
-7,326
| -1% | -$1.18M |
|
40
RTX Corp
RTX
$282B
| $98.2M | 0.36% |
1,002,531
-82,580
| -8% | -$8.09M |
|
41
Coca-Cola
KO
$349B
| $91.1M | 0.33% |
1,512,034
-32,056
| -2% | -$1.99M |
|
|
PPLI
42
People Inc
PPLI
$3.14B
| $91M | 0.33% |
1,785,758
-802,959
| -31% | -$36.8M |
|
43
Fortive
FTV
$18.5B
| $87.5M | 0.32% |
1,553,378
+15,248
| +1% | +$770K |
|
|
CSW
44
CSW Industrials
CSW
$4.73B
| $83.7M | 0.31% |
503,911
-4,637
| -0.9% | -$670K |
|
45
Brookfield Infrastructure Partners
BIP
$18.9B
| $83.7M | 0.31% |
2,293,477
-65,563
| -3% | -$2.34M |
|
46
Ally Financial
ALLY
$13.4B
| $79.5M | 0.29% |
2,943,550
+61,819
| +2% | +$1.64M |
|
47
FMC Excelsior Focus Equity ETF
FMCX
$113M
| $75.9M | 0.28% |
3,013,907
+10,138
| +0.3% | +$242K |
|
48
Vanguard S&P 500 ETF
VOO
$967B
| $67.7M | 0.25% |
166,262
+9,495
| +6% | +$3.66M |
|
49
US Bancorp
USB
$98.7B
| $67.4M | 0.25% |
2,040,737
-143,446
| -7% | -$4.64M |
|
|
XIFR
50
XPLR Infrastructure LP
XIFR
$1.18B
| $66.7M | 0.24% |
1,137,746
+1,061,335
| +1,389% | +$63.8M |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.